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1. Introduction
Intracranial hemorrhage (ICH) is a major source of neonatal morbidity and mortality. In full-
term infants, it most often occurs during labor as the result of mechanical factors; however, in
the pre-term infants it can occur even prior to labor or as late as the second week of life usually
as a result of hemodynamic instability. Besides etiology, the location of hemorrhage, clinical
presentation and neurological outcome also differs in the term and preterm infants. It is
important for the radiologists to provide an accurate anatomic description of the compart‐
ment(s) confining the hemorrhage, as correct location may be an indicator to the underlying
cause and provide a roadmap to the neurosurgeons if intervention is required. The knowledge
of the anatomic compartments is vital for interpreting the imaging findings in case of ICH and
formulating a differential diagnosis. Cranial ultrasound is often used as the first imaging
modality for newborns. CT is the preferred diagnostic study for evaluation of acute intracranial
hemorrhage. MRI is indicated when subarachnoid bleed or posterior fossa hemorrhage is
suspected. Prevention of ICH is a subject of great interest in premature newborns. Prenatal
prophylaxis and improved obstetric and neonatal care in general markedly reduces the stress
to premature fetus and neonate.
2. Etiopathogenesis
Intracranial hemorrhage (ICH) is perhaps the most dramatic manifestation inherited in the
birth process. The etiology of ICH differs according to the gestational age of the infant and the
site of hemorrhage.
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Of all types of ICHs, germinal matrix-intraventricular hemorrhage (GM-IVH) by far is the most
common and distinctive pathology in premature infants. The pathogenesis of GM-IVH is
multifactorial. It involves a combination of vascular-anatomic immaturity and complex
hemodynamic factors. The role of inflammatory and genetic factors is currently under
investigation. Germinal matrix (GM) is a highly vascular structure and the source of develop‐
ing brain cells (neuronal and glial cells). The tissue surrounds the fetal ventricular system and
gradually involutes to reside over the body of the caudate between 24 and 28 weeks of
gestation, at the level of head of caudate nucleus in the caudothalamic groove between 28 and
34 weeks of gestation, and finally completely regresses and converts into normal cerebral
parenchyma by the 36th week of gestation. The capillary network of germinal matrix is
composed of high-caliber, thin-walled (deficient in muscularis layer) and immature fragile
vessels predisposed to rupture. Furthermore, GM lies within an arterial end zone, and is
directly connected to the deep galenic venous system, thereby exposing it to insults of arterial
ischemic-reperfusion and to venous congestion.[1,2,3] The rupture hemorrhage of the vulner‐
able GM requires the coexistence of several intrinsic and extrinsic hemodynamic factors.
Premature infants are believed to have impaired cerebral pressure autoregulation (a major
intrinsic factor) that renders these infants susceptible to both cerebral hypoperfusion and
ischemia at the border zone GM vessels and hence the rupture of fragile germinal matrix
vessels. In term infants, a well developed cerebral pressure autoregulation mechanism
maintains a relatively constant cerebral blood flow (CBF) across a range of cerebral perfusion
pressures.[4] Various extrinsic hemodynamic factors that potentially interfere with the
integrity of the vulnerable GM include low CBF (hypotensive events and frank perinatal
asphyxia), high CBF (hypertension, bolus fluid infusion, hypercarbia and low hematocrit),
fluctuating CBF, and factors causing increased cerebral venous pressure (respiratory distress
syndrome, positive pressure ventilation, pneumothorax, or pulmonary hemorrhage).[1,2]
Immature deep galenic system, in a preterm infant, which is prone to venous congestion and
stasis is another major factor responsible for development of GM-IVH and its complications.
Immature cerebral venous system has several vulnerabilities because (i) development of
cerebral venous system occurs late in relation to that of the arteries, (ii) there is sequential
remodeling and considerable individual variation in the pattern and size of different veins
entering the internal cerebral veins, (iii) immature veins have high caliber and thin wall, they
branch parallel to the ventricle, hence tend to collapse, (iv) because of relative paucity of
superficial cortical veins between 24 and 28 weeks of gestation, most of the cerebral venous
drainage is dependent on the deep galenic system that drains GM and most of the white matter,
and (v) the periventricular veins, particularly the terminal (thalamostriate) vein, which is the
main vein draining the white matter passes directly through the GM and takes a U-turn to join
the internal cerebral vein.[1,2]
In term newborns ICH is relatively uncommon and has a different etiology. ICH in term
neonates may be subarachnoid, subdural, intraventricular, parenchymal or epidural in
location. In clinical practice, hemorrhage involving multiple compartments is not unusual.[5]
Both subdural and subarachnoid hemorrhage in a term newborn is associated with birth
trauma either from forceps delivery/vacuum extraction or unassisted vaginal delivery. Vertical
moulding of skull causes stretching and tearing of blood vessels of tentorium, falx and dura
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to produce SDH, while tearing of bridging blood vessels or dural sinuses causes SAH.[5,6]
Intraparenchymal hemorrhage (intracerebral or cerebellar) is less frequent than subdural and
subarachnoid hemorrhage in term newborns. Intraparenchymal bleeding in the full term
newborn may occur as a result of birth asphyxia, instrumental delivery, infection, primary
clotting abnormality or congenital vascular abnormality.[7] The incidence of intraventricular
hemorrhage (IVH) in term newborns (4.6%) compared to preterm newborn (50%) is very low,
probably due to greater maturity of the brain at term. In the term newborn, intraventricular
hemorrhage commonly originate from choroid plexus (cryptic hemangioma) or as an extension
of the thalamic hemorrhage or subependymal GM bleed.[8] Epidural hemorrhage is rare in
term newborn because the middle meningeal artery, which is not yet encased within the bone,
moves freely away from displacements of the skull. Epidural hemorrhage, however, may occur
in the newborn, in absence of skull fracture, during a difficult forceps extraction when an
external forceps causes the outer layer of dura to detach from the inner table of skull. [9]
Several risk factors have been reported in term newborns with ICH. Maternal risk factors
causing ICH in the first neonatal week includes usage of drugs (such as aspirin, cocaine),
pregnancy-induced hypertension, placental abruption, placental alloimmunization and
autoimmune disorders. Major perinatal risk factor are birth trauma, low Apgar score, resus‐
citation at birth, thrombocytopenia, breastfed infants who received no vitamin K, inherited
coagulopathy, disseminated intravascular coagulopathy, increased cerebral venous pressure,
prolonged labor, unassisted vaginal delivery, forceps delivery, suction cup, and cesarean-
section (sometimes).[10]
3. Clinical presentation
GM-IVH in premature infant is typically diagnosed during the first week of life, 50% on the
first day and 90% within the first 4 days. GM-IVH is usually subependymal and asymptomatic,
diagnosed by routine screening cranial ultrasound (CUS) in 25-50% of premature infants less
than 1,500 gm birth weight and less than 32 weeks’ gestation. Clinically symptomatic cases
with large hemorrhage and its complication may present with various degree of altered
consciousness, cardiorespiratory deterioration, unexplained drop in hematocrit, acidosis,
blood glucose alteration, inappropriate antidiuretic hormone secretion, severe apnea or
neonatal seizure, bulging fontanelles, abnormal eye movement or alignment, abnormal
pupillary response, and abnormal neuromotor examination (hypotonia, decresased motility,
tight popliteal angle). [1,3]
The pattern of hemorrhage also differs from GM hemorrhage common in preterm newborns
in having a later onset between the 4th and 10th days after birth. Neurologic manifestations like
neonatal seizure, decreased level of consciousness, increased intracranial pressure are the most
common presentations of ICH in term newborns. The newborn’s history, maternal and family
history and perinatal risk factors may suggest the diagnosis of ICH.[5]
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4. Role of neuroimaging
4.1. Germinal Matrix-Intraventricular Hemorrhage (GM-IVH) in preterm infants
For years neonatal cranial ultrasound (CUS) has been the key diagnostic tool for GM-IVH in
premature infants due to its widespread availability, relative low cost, direct bedside scanning
and high resolution to detect GM-IVH. CUS is nearly as accurate as CT but much less stressful
for an ill premature infant. Diagnostic screening with CUS is recommended in all premature
infants (less than 1,500 gm birth weight and less than 32 weeks’ gestation) during the second
week of life (after which further bleeding is uncommon) or earlier if clinical conditions indicate.
[11] Doppler ultrasound can also be used for the imaging and flow velocity measurements of
the terminal vein.[12] CT had been used in the original studies to grade the GM-IVH, however,
it is no longer recommended for diagnostic purpose due to the adverse effect produce by
ionizing radiation on immature brain. MRI is superior to CUS and CT for detection of associ‐
ated white matter (WM) abnormalities and for identifying hemorrhages particularly small
petechial hemorrhage, subacute to chronic hemorrhage and for extracerebral or posterior fossa
hemorrhage.[13] The severity of GM-IVH has been evaluated by Papile[14] and Volpe’s[15]
grading system. When bleeding is confined to the subependymal region, it is classified as grade
I; grade II is extension of hemorrhage into non distended lateral ventricle(s) where blood fills
less than 50% of the ventricular diameter; in grade III, extensive intraventricular hemorrhage
fills greater than 50% of the ventricular diameter leading to hydrocephalus; whereas, grade IV
is periventricular hemorrhagic infarction (PVHI).[14,15] Most cases have grade I or grade II
intraventricular hemorrhage and do not show late sequelae.[16,17] Infants with grade III or IV
hemorrhage have high incidence of neurologic sequelae (approx. 30% will have severe cerebral
palsy or mental retardation).[18,19]
Once GM-IVH is diagnosed, follow-up CUS examinations are necessary to determine its
complications like periventricular hemorrhagic infarction (PVHI) and post-hemorrhagic
hydrocephalus (PHH) and associated cerebellar hemorrhagic injury (CHI), periventricular
leukomalacia (PVL), and SAH.[1,4]
Periventricular hemorrhagic infarction (PVHI), classified as grade IV GM-IVH, is a complica‐
tion of GM-IVH. As previously thought, it is not due to rupture of ependymal lining and
extension of intraventricular hemorrhage into the periventricular white matter; rather it occurs
due to compression of the terminal vein by GM-IVH resulting in impaired venous drainage
and congestion of the medullary veins, which in turn leads to hypoxia-ischemia, infarction
and finally hemorrhagic transformation in the periventricular white matter.[20] PVHI can be
associated with all grades of GM-IVH (grade I-III) and may be unilateral (65-75% cases) or
bilateral (symmetrical or asymmetrical). The severity of PVHI can be graded based on three
CUS parameters: (i) extent, (ii) bilaterality, and (ii) the presence of a midline shift. [21]
Decreased flow velocity and displacement of the terminal vein can be seen in surviving infants
with PVHI using Doppler flow velocimetry.[22] PVHI is in the distribution of the fan-shaped
periventricular medullary veins. Intravascular thrombi within the medullary veins can be
demonstrated on T2-weighted MRI as linear abnormalities in the WM of centrum semiovale.
[20] In living infants, venous infarction usually evolves to produce a porencephalic cyst and
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rarely multiple cysts. The evolving cyst(s) are associated with the destruction of motor and
associative WM axons and preoligodendrocytes. These infants have a high incidence of
hemiplegia later in their life.[23] Asymmetric myelination of the posterior limb of the internal
capsule on MRI at term has been suggested as an early predictor of hemiplegia in PVHI. [24]
Incidence of ventricular dilatation increases with the severity of GM-IVH. CUS is an ideal tool
for monitoring ventricular dilatation in newborns with open fontanelle. Detailed imaging with
MRI is usually required prior to shunt surgery and for monitoring the progression or shunt
complication after closure of the fontanelle. Posthemorrhagic hydrocephalus (PHH) may be
progressive (due to obstruction by blood clot or secondary inflammatory changes which
interferes with CSF flow), nonprogressive (due to parenchymal loss secondary to PVHI or
PVL) or a combination of the two. PHH survivors with grade III and IV GM-IVH have high
risk of significant neurodevelopmental sequelae (e.g. quadriparetic cerebral palsy and/or
profound mental retardation).[3,25]
A very high association (77%) has been reported between the cerebellar hemorrhagic injury
(CHI) and supratentorial GM-IVH. CHI can result from cerebellar GM hemorrhage (subepen‐
dymal or subpial), primary hemorrhage, ischemic hemorrhagic transformation of either
arterial or venous origin, or dissection of blood through the fourth ventricle or subarachnoid
spaces following massive supratentorial GM-IVH. The location of CHI could be unilateral,
vermian, bilateral or a combination of these. Mastoid CUS view helps to detect CHI in 3% of
premature infants. MRI detects small petechial cerebellar hemorrhages not visible on CUS.
CHI may eventually lead to several types of atrophic changes. 40% of CHI survivors have
global developmental (cognitive and social communication disabilities) and functional deficits
(motor deficits).[3,26]
A strong association between GM-IVH and periventricular leukomalacia (PVL) has been
suggested. GM-IVH and PVL may develop in parallel, the ischemic injury may injure the GM
and the periventricular WM leading to both GM-IVH and PVL. The CUS markers of cystic and
diffuse PVL include echolucencies, echodensities and nonprogressive ventriculomegaly.[3,27]
Subarachnoid hemorrhage (SAH) is relatively common in premature infants with GM-IVH.
The true incidence of SAH is not known as it is difficult to visualize the extra-axial hemorrhage
by CUS. MRI is the modality of choice to detect SAH. SAH could be one of the reasons for PHH
(obstructive arachnoiditis), neonatal seizure (irritation of cerebral convexity) and cerebral/
cerebellar growth impairment.[28,29]
Impaired cerebellar and supratentorial gray matter growth has been reported in GM-IVH
survivors. The complicated GM-IVH (PVHI and PVL) causes impaired growth and develop‐
ment of the contralateral cerebellar hemisphere due to injury to specific supratentorial
projections (crossed cerebellar diaschisis).[28] The uncomplicated GM-IVH (without paren‐
chymal involvement) is associated with impaired growth of the supratentorial gray matter,
probably because the GM destruction prevents the neuronal and astrocyte precursor cells from
reaching their cortical destination. In addition, SAH (circulating free radical) may directly
injure the cerebral cortex surface.[29]
Intracranial Hemorrhage in the Newborn
http://dx.doi.org/10.5772/58476
5
4.2. Intracranial hemorrhage (ICH) in term newborns
Subarachnoid hemorrhage (SAH) is the most common type of hemorrhage among the
symptomatic term newborns.[6] On FLAIR (fluid attenuated inversion recovery) sequence of
MRI, SAH is detected as hyperattenuating fluid in the basal subarachnoid spaces or along the
cerebral sulci. Extensive subarachnoid hemorrhage may be difficult to distinguish from
subdural hemorrhage and the two may co-exist. [3]
Subdural hemorrhage (SDH) is the most frequent hemorrhage among asymptomatic term
newborns.[5] SDH is usually infratentorial, may result from rupture of the vein of Galen,
straight or transverse sinus. On imaging, SDH can be seen as a crescent-shaped hyperattenu‐
ating region conforming to the adjacent brain. Small posterior fossa SDHs are common in
infants and are usually of no clinical significance; however, when large, may result in com‐
pression of the brain stem and death. Infratentorial SDH may be difficult to distinguish from
transverse sinus thrombosis. The two may co-exist or a SDH may compress the sinus predis‐
posing to thrombosis. Convexity SDH are less common than posterior fossa hemorrhage and
the two may co-exist. Rupture of superficial cortical veins gives rise to convexity SDH, which
may be accompanied by SAH. Convexity SDH is mainly unilateral. Large convexity hemor‐
rhage may be associated with infarction of the brain either from arterial occlusion or impaired
venous drainage. Associated parenchymal hemorrhage either due to hemorrhagic tendency
or in association with infarction may also occur.[3]
Large SDH may result in impairment of CSF flow and associated ventricular dilatation or
widening of the extracerebral space (external hydrocephalus). The evolution of SDH may
result in the formation of a subdural effusion which may remain at the site of a previous SDH
for months and may be associated with rebleeding.[3]
Parenchymal hemorrhagic lesions may co-exist with hemorrhage elsewhere in the cranium.
Parenchymal hemorrhage may be focal or multifocal and of any size. Multifocal small
hemorrhages may be found in term infants presenting with convulsions during the first few
days of life. Thalamic hemorrhage is usually unilateral and associated with IVH. Primary
thalamic hemorrhage needs to be distinguished from the bilateral thalamic abnormalities seen
in HIE. The thalamic lesions in HIE are focal, usually involving the lateral thalamic nuclei and
sometimes the medial nuclei, these lesion have high signal intensity on T1-weighted images
and low signal intensity on T2-weighted images due to capillary proliferation in region of
infarction (not due to hemorrhage). However, infants with HIE may develop large intracranial
hemorrhage. Basal ganglia hemorrhage may occur as an isolated event in term newborn,
sometimes it is difficult to differentiate it from a hemorrhagic infarction involving a deep
branch of middle cerebral artery. Cerebellar hemorrhage may be primary, secondary to venous
infarction or may complicate massive intraventricular or subarachnoid hemorrhage. The MR
appearance of parenchymal hemorrhage varies with time depending on the oxidation state of
hemoglobin.[30]
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5. Prevention and management
5.1. GM-IVH in preterm infants
Modern practice should emphasize on (i) prevention of GM-IVH, (ii) halting its progression,
and (iii) reducing its complications. Important preventive measures include (i) special obstetric
care for high-risk pregnancies, (ii) treatment of bacterial vaginosis for reducing premature
delivery, (iii) prevention of imminent premature labor using tocolytic agents, cesarean section
delivery in selected cases, and (iv) maternal administration of magnesium sulfate. In addition,
optimal ventilation and strict hemodynamic control of the premature infant are the corner‐
stones of preventing GM-IVH and its progression. Several postnatal pharmacological agents
for prevention of GM-IVH are still under trial.[25,31,32]
PHH, a complication of GM-IVH has a very unpredictable course. 60% of the infants may
undergo spontaneous resolution while 40% may require a ventriculoperitoneal shunt, the
definitive treatment of progressive PHH.[25] Repeated lumbar puncture may temporarily
arrest the progression of PHH, but the long-term benefit of this approach remains unknown.[3]
5.2. ICH in term newborns
The single most important primary prevention is successful accomplishment of a vaginal
delivery with or without obstetric instrument. However, forceful vaginal delivery should not
be attempted if either vacuum extraction or forceps delivery has failed.[33]
Medical interventions should be implemented on the very first clinical suspension of ICH. The
goal of medical therapy is to provide adequate ventilation, prevent metabolic acidosis, to keep
vital organs well perfused and to control seizure activity. Sick newborns with ICH are managed
in the intensive care unit. Any treatable etiological factor (e.g. sepsis, dehydration, thrombo‐
cytopenia, vitamin K deficiency or coagulopathy) should be identified and treated promptly.
Most symptomatic newborns with intracranial hemorrhage do not require neurosurgical
intervention. Neurosurgical intervention could, however, be lifesaving in a situation in which
there is a sudden clinical deterioration primarily due to rise in intracranial pressure as a result
of massive ICH and PHH.[34] The secondary prevention is to limit the extent of parenchymal
injury to the brain due to neurosurgery or hematoma.[35]
6. Summary
GM-IVH and its complications have potential impact on morbidity, mortality and long-term
neurodevelopmental outcome. The mechanism of GM-IVH is multifactorial and involves a
combination of vascular anatomic immaturity and complex hemodynamic factors. Goals are
prevention of GM-IVH, halting its progression and reducing its complications.
A strong association between traumatic deliveries especially vacuum extraction/forceps
delivery and hemorrhagic lesions has been well established in term newborns. Hemorrhage
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is often present at more than one site. MRI can be used to time the onset of lesions. Hemorrhage
may be primary or secondary and occur within an arterial or venous infarct. Neurodevelop‐
mental outcome varies with the site of hemorrhage and the underlying cause. In the majority
of term newborns with ICH, medical therapy is the primary mode of treatment; rarely, surgical
intervention may be needed in selected cases.
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